At this time, posts about iCure are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net purchased 1,000 shares today. iCure is known as a company possessing core technology for transdermal drug delivery systems.


As of 12:30 PM on the 23rd, iCure's stock price is 62,600 KRW, down 3.99% from the previous day, with a trading volume of 276,854 shares, which is about 11.53% of the 5-day average trading volume.


In addition to iCure, posts by investors are also surging for Medicox (054180), Telechips (054450), and WeMade (112040).



※Source: AI Investment Assistant AI Racciro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing